Cannabis Classification Timeline
Explore the comprehensive history of cannabis and marijuana classification in the United States, from early medicinal use to the proposed Schedule III rescheduling.
REGULATORY HISTORY
From Medicine to Schedule I to Reform
Understanding the history of cannabis classification is essential for navigating today's complex regulatory environment and preparing for future changes.
1840-1900
1840-1900
Early Medicinal Use
Cannabis was widely used medicinally in the United States during this period. It was commonly available in pharmacies and used to treat various ailments including pain, nausea, and anxiety. The U.S. Pharmacopeia listed cannabis as a recognized medicine in 1850.
Key Fact
Cannabis extracts were sold by major pharmaceutical companies including Eli Lilly, Parke-Davis, and Squibb.
1906
1906
Pure Food and Drug Act
The Pure Food and Drug Act was enacted, requiring labeling of cannabis-containing products. This marked the beginning of federal oversight of medicinal substances, though cannabis remained legal for medical use.
1915-1937
1915-1937
Era of State Criminalization
California became the first state to criminalize cannabis in 1915. By 1937, 23 states had enacted laws criminalizing cannabis possession. This period saw the rise of anti-cannabis sentiment, often fueled by xenophobic attitudes and sensationalist media coverage.
23
States with prohibition by 1937
1915
California - first state to prohibit
1937
1937
The Marihuana Tax Act
Congress passed the Marihuana Tax Act, creating the first federal regulation of cannabis. While not technically criminalizing cannabis, it imposed a complex regulatory framework and prohibitive taxes that made legal use virtually impossible.
AMA Opposition
The American Medical Association testified against the Act. Dr. William C. Woodward stated: "The American Medical Association knows of no evidence that marijuana is a dangerous drug."
1942
1942
Removed from U.S. Pharmacopeia
Cannabis was removed from the U.S. Pharmacopeia, officially eliminating its recognized medical status that had existed since 1850. This marked a significant turning point in the medical legitimacy of cannabis.
1968
1968
Leary v. United States
The Supreme Court struck down the Marihuana Tax Act as unconstitutional in Leary v. United States, ruling that it violated the Fifth Amendment right against self-incrimination. This decision set the stage for new federal legislation.
Constitutional Victory
Timothy Leary successfully challenged the 1937 Act, arguing that registering as a marijuana user would be self-incriminating.
1970
1970
Controlled Substances Act
Congress passed the Controlled Substances Act (CSA) as Title II of the Comprehensive Drug Abuse Prevention and Control Act. Cannabis was classified as Schedule I - defined as having no accepted medical use and high potential for abuse.
Schedule I Classification Means:
- No currently accepted medical use
- High potential for abuse
- Lack of accepted safety under medical supervision
- Same category as heroin and LSD
Note: Fentanyl, cocaine, and methamphetamine were classified as Schedule II - a less restrictive category.
1972
1972
The Shafer Commission
The National Commission on Marihuana and Drug Abuse, known as the Shafer Commission, released its report "Marihuana: A Signal of Misunderstanding." The bipartisan commission recommended decriminalizing personal possession and private use.
Commission Conclusion
"Marijuana use did not pose significant physical or psychological harm justifying criminal penalties for personal possession."
President Nixon declined to act on the commission's recommendations.
1973
1973
Drug Enforcement Administration
The DEA was established, consolidating federal drug enforcement under one agency. Oregon became the first state to decriminalize cannabis, reducing penalties for possession of up to one ounce to a $100 fine.
DEA Established
Federal enforcement consolidated
Oregon Decriminalizes
First state to reduce penalties
1978
1978
First State Medical Program
New Mexico became the first state to legally recognize cannabis's medical value, establishing a controlled program for therapeutic use. This marked the beginning of state-level medical cannabis recognition.
1996
1996
California Proposition 215
California became the first state to legalize medical cannabis through voter initiative. Proposition 215, the Compassionate Use Act, allowed patients with a doctor's recommendation to use cannabis for medical purposes.
Historic Vote
55.6% of California voters approved medical cannabis, creating direct conflict with federal Schedule I classification.
2012
2012
First Recreational States
Colorado and Washington became the first states to legalize adult-use (recreational) cannabis, creating regulated commercial markets that directly challenged federal prohibition.
Colorado
Amendment 64 - 55% approval
Washington
Initiative 502 - 56% approval
2014
2014
Agricultural Act (Farm Bill)
The 2014 Farm Bill created a legal distinction between hemp and marijuana, allowing state-authorized hemp pilot programs. Hemp was defined as cannabis containing less than 0.3% THC.
Hemp Definition
Cannabis sativa L. with THC concentration of 0.3% or less on a dry weight basis.
2018
2018
Agriculture Improvement Act
The 2018 Farm Bill removed hemp from the Controlled Substances Act entirely, federally legalizing hemp cultivation and hemp-derived products including CBD. This created the modern hemp industry.
Key Provisions:
- Hemp removed from Schedule I
- State-regulated cultivation programs authorized
- Interstate commerce of hemp products permitted
- USDA oversight of hemp production
2022
2022
Biden's Scheduling Review
On October 6, 2022, President Biden directed the Department of Health and Human Services (HHS) and the Attorney General to review marijuana's scheduling under federal law, citing disproportionate enforcement impacts and state-level reforms.
Executive Direction
Biden also issued pardons for federal simple possession convictions and urged governors to do the same at the state level.
2023
2023
Schedule III Recommendation
In August 2023, following an FDA scientific review, the Department of Health and Human Services formally recommended that the DEA reclassify cannabis from Schedule I to Schedule III - the first federal agency to recommend rescheduling.
Schedule III Would Mean:
- Recognized medical use with prescriptions
- Moderate to low potential for dependence
- Easier research access
- Tax deductions for cannabis businesses (IRC 280E relief)
2024
2024
Rescheduling Process Initiated
On May 21, 2024, the DEA published a Notice of Proposed Rulemaking (NPRM) to transfer marijuana from Schedule I to Schedule III. This initiated the formal rulemaking process with public comment period.
43,000+
Public comments received
38
States with medical cannabis
Process Ongoing
Administrative hearings and legal reviews continue. Final rule timeline remains pending as of late 2024.
Present
Present
The Federal-State Divide
Today, cannabis remains a Schedule I substance federally while being legal for medical use in 38 states and adult use in 24 states. This creates significant compliance challenges for financial institutions, operators, and federal agencies.
38
Medical States
24
Adult-Use States
$30B+
Annual Industry
Why Compliance Matters Now
With potential Schedule III reclassification on the horizon, financial institutions and federal agencies need examiner-ready compliance frameworks. HFA provides the infrastructure for this transition.
Sources & References
Historical information compiled from official government and academic sources